Rocket


Overview
Financials
News + Filings

 
 

Dermata Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues00
Cost of goods sold00
Gross profit00
Research and development1,607,8192,623,280
General and administrative1,565,0341,847,328
EBIT-3,172,853-4,470,608
Pre-tax income00
Income taxes00
Net income00
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy